EJHF Consensus Redefines Revascularization Role in Heart Failure With CAD
Consensus Statement Cardiology / Anticoagulation Practice-changing Grade: Low
Haring B, Iaconelli A, Perera D, et al.
Jul 24, 2026 · Published in: European Journal of Heart Failure
Is revascularization beneficial for heart failure patients with coronary artery disease?
Bayesian Synthesis Finds LAAO Fails Stroke Non-Inferiority Versus Anticoagulation
Analysis Cardiology / Anticoagulation Confirmatory Grade: Moderate
Athmakuri KS, Nandyal SR, Pamreddy HR, et al.
Jul 22, 2026 · Published in: Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
LAAO reduces bleeding but not strokes compared to anticoagulation.
AHA Scientific Statement on Caffeine and Cardiovascular Disease
Consensus Statement Cardiology / Anticoagulation Confirmatory Grade: Low
Marcus GM, Hu FB, van Dam RM, et al.
Jul 20, 2026 · Published in: Circulation
Caffeine's cardiovascular effects vary from coffee's benefits to energy drinks' risks.
2026 Dyslipidemia Guideline Expands Statin Eligibility to Lower-Risk Adults
Analysis Cardiology / Anticoagulation Confirmatory Grade: Moderate
Anderson TS, Wilson LM, Sussman JB
Jul 20, 2026 · Published in: JAMA
2026 guidelines broaden statin eligibility, reaching more younger adults.
Extended DAPT Cuts Ischemic Events in Multivessel CAD
Analysis Cardiology / Anticoagulation Practice-changing Grade: Moderate
Tian J, Wang Z, Wang Y, et al.
Jul 16, 2026 · Published in: N Engl J Med
Extended DAPT reduces ischemic events post-stent in multivessel CAD.
Aspirin Monotherapy Noninferior to Rivaroxaban Bridge After Arthroplasty
Analysis Cardiology / Anticoagulation Practice-changing Grade: High
Shivakumar S, Matino D, Zukor D, et al.
Jul 12, 2026 · Published in: N Engl J Med
Aspirin matches rivaroxaban's efficacy in preventing post-surgical blood clots.
Practical Framework for Managing Anticoagulant-Associated Bleeding
Analysis Cardiology / Anticoagulation Confirmatory Grade: Low
Galli M, Simeone B, Ten Berg J, et al.
Jul 8, 2026 · Published in: European Heart Journal. Acute Cardiovascular Care
Bleeding risks complicate anticoagulant therapy management in cardiovascular patients.
Most Post-Stroke Patients Miss Blood Pressure Targets in CONVINCE
Analysis Cardiology / Anticoagulation Confirmatory Grade: Moderate
Synnott P, Walsh C, Weimar C, et al.
Jul 6, 2026 · Published in: European Stroke Journal
Most post-stroke patients miss new BP guidelines.
Factor XIa Inhibitors: Indication-Specific Anticoagulation, Not Broad DOAC Replacement
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Low
Kidder E, Dhanesha N
Jul 1, 2026 · Published in: Current Opinion in Hematology
Factor XIa inhibitors could transform thrombosis prevention.
SGLT2 Inhibitor Uptake Rises but Misses Highest-Risk HFrEF Patients
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Low
Pulatov O, Kim SY, Grossman Z, et al.
Jun 29, 2026 · Published in: BMC Cardiovascular Disorders
In-hospital SGLT2 initiation slashes heart failure readmissions.
ESC and EACTS Issue Consensus on Antithrombotic Therapy After CABG
Consensus Statement Cardiology / Anticoagulation Inconclusive Grade: Low
Sandner S, Gaudino M, Agewall S, et al.
May 21, 2026 · Published in: European Heart Journal
Balance risks: Antithrombotic therapy post-bypass under scrutiny.
Asundexian Cuts Recurrent Stroke Without Excess Bleeding
Analysis Cardiology / Anticoagulation Practice-changing Grade: High
Sharma M, Dong Q, Hirano T, et al.
Apr 16, 2026 · Published in: N Engl J Med
Could a new anticoagulant improve stroke prevention?
Factor XI Inhibitors Cut Bleeding but Raise Ischemic Stroke in AF
Analysis Cardiology / Anticoagulation Confirmatory Grade: Low
Markides RIL, Koolaji S, Leader JH, et al.
Jun 1, 2025 · Published in: Journal of Thrombosis and Thrombolysis
Factor XI inhibitors reduce bleeding but may affect stroke prevention in atrial fibrillation.
Factor XI Antibody Abelacimab Cuts Bleeding Versus Rivaroxaban in AF
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Moderate
Ruff CT, Patel SM, Giugliano RP, et al.
Jan 23, 2025 · Published in: New England Journal of Medicine
Abelacimab cuts bleeding risk in atrial fibrillation patients.
OCEANIC-AF: Asundexian Fails Stroke Prevention Versus Apixaban
Analysis Cardiology / Anticoagulation Practice-changing Grade: Moderate
Piccini JP, Patel MR, Steffel J, et al.
Jan 2, 2025 · Published in: New England Journal of Medicine
Asundexian falls short on stroke prevention in AFib but cuts bleeding.